Perfil mutacional por secuenciacin de nueva generacin en cncer de pulmn de clulas no pequeas en poblacin mexicana
Texto completo
Figure
Documento similar
La determinación molecular es esencial para continuar optimizando el abordaje del cáncer de pulmón, por lo que es necesaria su inclusión en la cartera de servicios del Sistema
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.
Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: a retrospective multicentric cohort study. Sussman TA, Li H, Hobbs
Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study
BMH history of treated, stable breast cancer brain metastases, CI confidence interval, GPA graded prognostic assessment, OS overall survival, PFS progression-free survival, SD
11 Figure S4 Kaplan-Meier estimates of progression-free survival (A) and overall survival (B) according to tumour sidedness in patients with BRAF- and/or PIK3CA mutations (n=44)...
Metabolic Health Together with a Lipid Genetic Risk Score Predicts Survival of Small Cell Lung Cancer Patients..
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL):
